Target Information
MOTH, the premier ready-to-drink (RTD) cocktail brand in the UK, has secured a substantial investment of £4.6 million, led by the ProVen VCTs. Over the past three years, MOTH has experienced remarkable growth, with its premium canned cocktails now available in over 3,000 supermarkets across the UK. Holding a commanding 41% share of the premium RTD category in the UK off-trade market, MOTH sees one of its products sold every seven seconds, underscoring its popularity and market penetration.
This funding round is strategically aimed at reinforcing MOTH’s leadership in the UK market, accelerating its expansion into the US, and scaling its team on both sides of the Atlantic. Following successful launches in Massachusetts and Florida in 2023, the company is set to establish its first US office, thereby broadening its operational footprint.
Industry Overview in the UK
The ready-to-drink cocktail segment has emerged as the fastest-growing drinks category in the UK since 2018, as per industry reports. Consumer trends indicate a marked shift towards convenient drinking solutions, with many seeking premium quality options that do not compromise on flavor. MOTH has capitalized on this trend effectively, rapidly positioning itself as a key player in the market.
Moreover, MOTH’s product lineup features an array of ten popular cocktails, including classics such as the Margarita, Negroni, and Old Fashioned. Such variety not only addresses diverse consumer preferences but also reinforces the brand's commitment to quality and innovation.
With annual revenues skyrocketing—by 200% in 2022 and 150% in 2023—MOTH’s rapid growth is indicative of the brand meeting the rising demand for quality RTD products. The expansion of its team, which now consists of 35 employees in less than three years, further emphasizes the brand's robust trajectory.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Rationale Behind the Deal
This investment marks a pivotal moment for MOTH, enabling the brand to build upon its already impressive market presence. As the company prepares to extend its operations into the lucrative US market, the financing will support key initiatives such as marketing campaigns and talent acquisition. The anticipated growth trajectory in the US presents a substantial opportunity for MOTH to replicate its UK success.
Additionally, the backing from ProVen VCTs not only provides the necessary financial resources but also adds considerable expertise in scaling operations within the competitive beverage industry.
Investor Information
The investment firm behind this deal, ProVen VCTs, is well-known for supporting high-growth companies in the consumer sector. With a track record of successful investments. ProVen VCTs focuses on nurturing innovative concepts and helping businesses achieve their growth potential. Harry Thomas, the Portfolio Director at Beringea, emphasizes the remarkable progress MOTH has made and recognizes its potential for significant future growth, particularly in the US market.
View of Dealert
The expert opinion on this investment in MOTH aligns with the company’s promising outlook in both the UK and US markets. MOTH is not only riding the wave of the RTD cocktail trend but is also positioned to thrive amidst growing consumer demand for premium beverage options. Given its substantial market share in the UK and successful initial US endeavors, the potential for success appears strong.
The expectations for growth in the US, particularly as MOTH establishes its presence there, could lead to expanded revenues and brand recognition. Moreover, the commitment of MOTH’s leadership to maintain high quality and innovative products strengthens its competitive advantage.
However, careful execution of its US strategy will be vital, as the market presents unique challenges. If MOTH can effectively navigate these challenges and leverage its existing strengths, this investment could indeed prove to be a highly lucrative opportunity.
Similar Deals
Growth Lending → A & R Care Limited
2025
ProVen VCTs
invested in
MOTH
in 2024
in a Growth Equity deal
Disclosed details
Transaction Size: $6M